, a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, today announced dosing of the first pat
(NASDAQ: ESPR) a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class oral low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers today announced it will h
hypercholesterolemia与发音含义,同义词,反义词,翻译,刑和更多的